News

What Is Semaglutide Used For? A Plain Guide

Creator: Julian Reyes, Health Writer
Published: 2026-09-09

Semaglutide has different jobs depending on the brand: blood sugar control, heart or kidney risk reduction, long-term weight management, or certain liver disease. Here is the plain list before a first visit.

Julian Reyes, Health Writer September 9, 2026 6 min read

A woman sits beside a raised garden bed holding a small pot of seedlings

The short version

Semaglutide's approved uses depend on the product: type 2 diabetes, specific heart or kidney risk reduction, long-term weight management, or noncirrhotic MASH with moderate-to-advanced liver scarring.
In STEP 1, average weight change at 68 weeks was 14.9% with semaglutide and lifestyle support versus 2.4% with placebo and the same support.
In SELECT, a major cardiovascular event occurred in 6.5% of the semaglutide group and 8.0% of the placebo group; participants already had cardiovascular disease and overweight or obesity.
In FLOW, the combined major kidney outcome was 24% less frequent with semaglutide than placebo among 3,533 people with both type 2 diabetes and chronic kidney disease.
In ESSENCE, MASH cleared without worse scarring in 62.9% with semaglutide and 34.3% with placebo at 72 weeks; longer follow-up is still underway.
Compounded semaglutide is a separate, patient-specific prescription; it does not inherit every brand indication, and the reviewing provider decides whether its use is medically appropriate.

What is semaglutide used for? In the U.S., its brand labels cover type 2 diabetes, reducing certain heart and kidney risks, chronic weight management, and one form of liver disease called MASH. The exact use depends on the product. Ozempic, Rybelsus, Ozempic tablets, and Wegovy aren't interchangeable names for every purpose. Compounded semaglutide is separate from those brands, and its use is a prescriber's decision.

Semaglutide is a GLP-1 receptor agonist, a medicine that copies a natural gut-hormone signal. It helps the body release insulin when blood sugar is high, slows food leaving the stomach, and changes appetite signals. How semaglutide works explains that part in more detail.

What is semaglutide used for? The plain list

An indication is simply the specific job listed on a medicine's reviewed label. Here is the current U.S. list by brand and form.

Brand and form	Approved use	In plain English
Ozempic injection	Type 2 diabetes; cardiovascular risk reduction in adults with type 2 diabetes and established cardiovascular disease; kidney and cardiovascular risk reduction in adults with type 2 diabetes and chronic kidney disease	Blood sugar control, plus protection from certain major heart and kidney outcomes in specific higher-risk groups
Rybelsus and Ozempic tablets	Type 2 diabetes; cardiovascular risk reduction in adults with type 2 diabetes who are at high risk	Oral semaglutide for blood sugar, with a heart-risk use for a defined higher-risk group
Wegovy injection	Long-term weight management; cardiovascular risk reduction in adults with established cardiovascular disease and overweight or obesity; noncirrhotic MASH with moderate-to-advanced fibrosis in adults	Weight care, a specific heart-risk use, and a specific form of liver disease
Wegovy tablets	Long-term weight management in adults; the same cardiovascular risk use listed for Wegovy injection	An oral option for the two adult uses; its label does not include pediatric weight management or MASH

MASH means metabolic dysfunction-associated steatohepatitis: fat buildup has led to liver inflammation and scarring. Wegovy's MASH use is limited to adults without cirrhosis who have moderate-to-advanced scarring. It received accelerated approval, meaning FDA accepted an earlier measure while a longer study continues to test outcomes that matter to patients.

For a fuller name-and-form map, see semaglutide brand names.

Why the approved uses are so specific

The labels follow the people and outcomes actually studied. They don't mean every form was tested for every goal.

For weight management, a 2021 trial of 1,961 adults called STEP 1 found average weight change of 14.9% with semaglutide and lifestyle support, versus 2.4% with placebo and the same support, after 68 weeks. Those are group averages, not a forecast for one person (New England Journal of Medicine, 2021).

For heart risk, the 2023 SELECT trial enrolled 17,604 adults who already had cardiovascular disease and had overweight or obesity, but not diabetes. A major heart event occurred in 6.5% of the semaglutide group and 8.0% of the placebo group (New England Journal of Medicine, 2023). That narrow population is why the Wegovy heart indication isn't a general promise of heart protection.

For kidney risk, the 2024 FLOW trial followed 3,533 people with both type 2 diabetes and chronic kidney disease. Its combined major kidney outcome was 24% less frequent in the semaglutide group than with placebo (New England Journal of Medicine, 2024). Chronic kidney disease means kidney function or damage has stayed abnormal over time.

For MASH, the ongoing ESSENCE trial reported an interim look at 800 adults. At 72 weeks, MASH cleared without worse scarring in 62.9% of the semaglutide group and 34.3% of the placebo group; scarring improved without worse MASH in 36.8% and 22.4%, respectively (New England Journal of Medicine, 2025). The trial is still following people to learn whether those tissue changes lead to fewer serious liver outcomes.

What off-label use means

Off-label means a clinician prescribes an approved medicine for a use, age group, or form that isn't listed on that product's label. It can be a legitimate medical decision. It also means the evidence may be thinner, and the brand cannot be treated as if it carries an indication it does not.

Ozempic is the common example. Its injection label is for type 2 diabetes and certain heart and kidney risks, not weight management. A clinician may consider it off-label in another situation, while Wegovy has the weight-management label. The molecule is the same; the products, studied doses, and listed uses are not.

As of September 6, 2026, the day this article was written, a randomized trial in the American Journal of Psychiatry published online July 29 studied oral semaglutide for eight weeks in 50 adults with moderate or severe alcohol use disorder. A randomized trial assigns treatment by chance. Semaglutide did not significantly improve the study's main lab measure of craving or drinks per day, although it lowered heavy-drinking days and several secondary measures, the other outcomes researchers tracked. That is early research, not an approved alcohol-use treatment.

What compounded semaglutide is used for in practice

Compounded semaglutide is prepared by a licensed pharmacy for an individual patient from a clinician's prescription. In practice, a provider may consider it for a patient-specific weight-management or metabolic need. It does not inherit every Ozempic or Wegovy indication just because the active molecule has been studied under those brands.

Through Promise, semaglutide is dispensed as a compounded medication, which is different from an FDA-approved product: the formulation offered here is not FDA-approved. FDA explains that compounded drugs do not go through its premarket review for safety, effectiveness, or quality (FDA's GLP-1 compounding information).

That distinction is about the product, not a shortcut around medical judgment. A licensed provider reviews every request, not everyone qualifies, and a provider may still prescribe a compounded formulation when medically appropriate; that decision is between the patient and the doctor. Compounded semaglutide covers how the prescription and pharmacy route differs from a branded pen or tablet.

Why a provider may also discuss tirzepatide

Tirzepatide is a different molecule. It works through GLP-1 plus a second signal called GIP, a gut hormone involved in insulin and appetite. A provider may compare the two when the goal is weight or blood-sugar care, but they aren't two brands of one drug and shouldn't be combined. Semaglutide versus tirzepatide walks through that choice without turning it into a winner-take-all ranking.

What matters before a first visit

A first visit should match the goal to the right product and check the history that changes the risk. That includes pregnancy plans, prior pancreatitis or gallbladder trouble, diabetic eye disease, severe stomach-emptying problems, and all current medicines. Semaglutide labels also carry a boxed warning about thyroid C-cell tumors seen in rodents and rule out use with a personal or family history of medullary thyroid carcinoma, a rare thyroid cancer, or MEN 2, an inherited tumor syndrome.

The useful starting question isn't simply whether semaglutide can be used for something. It is which form has evidence for the goal, whether the label fits, and whether the reviewing clinician thinks the expected benefit is worth the risk for that person.

Common questions

What are the main uses of semaglutide?

Semaglutide's labeled uses include type 2 diabetes, long-term weight management, reducing certain major heart risks, reducing certain kidney and cardiovascular risks in adults with type 2 diabetes and chronic kidney disease, and treating noncirrhotic MASH with moderate-to-advanced liver scarring. The exact use depends on whether the product is Ozempic, Rybelsus, Ozempic tablets, or Wegovy.

Is Ozempic used for weight loss?

Ozempic's U.S. injection label does not list weight management. It lists blood-sugar control in adults with type 2 diabetes, plus specific cardiovascular and kidney-risk uses in certain adults with type 2 diabetes. A clinician may prescribe a medicine off-label, but Wegovy is the semaglutide brand whose label includes long-term weight management.

Are Rybelsus and Wegovy tablets used for the same thing?

They contain the same active molecule but have different labels. Rybelsus and Ozempic tablets are used for adults with type 2 diabetes and for reducing major cardiovascular events in a defined high-risk diabetes group. Wegovy tablets are used for long-term weight management in adults and for a specific cardiovascular-risk group with established disease and overweight or obesity.

What is compounded semaglutide used for?

A clinician may consider compounded semaglutide for an individual patient's weight-management or metabolic need when medically appropriate. It is a separate pharmacy-prepared prescription, not Ozempic, Rybelsus, or Wegovy, and it does not automatically carry the brands' indications. The prescriber decides whether the evidence, patient's history, and available options support its use.

What does off-label semaglutide use mean?

Off-label use means a clinician prescribes an approved medicine outside a use, age group, or form listed on that product's label. It is a recognized part of medical practice, but it is not the same as a labeled indication. The clinician should be able to explain the evidence, uncertainty, alternatives, and why that choice fits the individual patient.

Who may not qualify for semaglutide?

Semaglutide labels rule out people with a personal or family history of medullary thyroid carcinoma or MEN 2, and other histories may change the decision. Pregnancy plans, prior pancreatitis or gallbladder disease, diabetic eye disease, severe stomach-emptying problems, and interacting medicines all matter. The reviewing provider decides after seeing the full medical history.